1 / 7

Europe In-vitro Diagnostics Market Analysis and Forecasts to 2024 Show Consistent Growth

Europe in-vitro diagnostics market should experience substantial growth in the upcoming years due to increasing adoption of technologically advanced diagnostic equipment available.

madhurip3918
Download Presentation

Europe In-vitro Diagnostics Market Analysis and Forecasts to 2024 Show Consistent Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. In-vitro Diagnostics Market in Europe is projected to surpass $21 bn by 2024: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. Key Insights from Europe In-vitro Diagnostics Market :  • According to Graphical Research, Europe In-vitro Diagnostics Market to reach $21 bn by 2024. • Improvement in healthcare infrastructure will drive Europe in-vitro diagnostics market growth. Majority of the population staying in developed countries rely on healthcare facilities developed by the public healthcare sector that has lower cost structure thereby will escalate demand for cost-effective diagnostic services augmenting industry growth. • Regulations implemented by the European Diagnostic Clusters Alliance (EDCA) has enforced specific guidelines for manufacturers of the in-vitro diagnostics tools and equipment to meet patient’s safety demand thereby will augment in-vitro diagnostic industry growth. • In-vitro diagnostic instruments segment will grow at 4.9% during the forecast timeframe owing to increasing number of laboratories equipped with instruments of superior quality. According to Global Genes, more than 30 million people suffer from rare diseases in Europe that require critical monitoring and diagnosis at gene level that should escalate the demand for diagnostic instruments. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Continued... • In-vitro diagnostic services segment held an enormous share of 78.9% in 2017 and is projected to grow significantly over the forecast timeframe as a result of growing geriatric population globally that will augment demand for in-vitro diagnostic services influencing the segmental growth positively. • Immunoassays or immunochemistry segment was valued at USD 3.0 billion in 2017 and high growth can be accounted to various benefits offered by these tests. • Cardiology segment will grow at 5.9% during the forecast timeline as a result of increasing incidence of cardiovascular diseases due to tobacco smoking, lack of physical activity, consumption of alcohol and unhealthy diet that will drive the segmental growth. • Laboratories segment held enormous revenue share of 29.4% in 2017 due to presence of various growth opportunities such as availability of skilled labor to work increasing the level of operational efficiency. High preference for laboratories with well-equipped diagnostic machines and equipment will thereby propel the segment growth. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. Continued... • Germany in-vitro diagnostics industry was valued at USD 2.1 billion in 2017 and is expected to grow exponentially over the estimated timeframe owing to the increasing number of technological advancements that are being incorporated in the medical diagnostic devices. For instance, major industry players such as Roche diagnostics have developed clinical diagnostic solutions and devices integrated with advanced technology enabling automation and increasing the operational efficiency that will thereby boost the preference for clinical chemistry, blood gas analysis and other such analytical devices that will stimulate the industry growth. • Major industry competitors operating in Europe in-vitro diagnostics market are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. These industry players have adopted certain strategic initiatives to gain competitive advantage and achieve sustainable profits. For instance, in January 2017, Grifols acquired Hologic unit working in R&D facility manufacturing assays and instruments based on nucleic acid testing technology. This acquisition will help in expanding the company’s product portfolio. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Europe In-vitro Diagnostics Market ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  6. Browse Full Market Research Report On Europe In-vitro Diagnostics Market  @ https://bit.ly/2D9tAPG Request for a Sample of this Research Report @ https://bit.ly/2GIv7OB ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  7. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related